Search
Vanda Pharmaceuticals Inc
VNDAAdd to Watchlist
3.880USD
+0.090+2.37%
Close 11-02 16:00（ET）
234.62MMarket Cap
LossP/E TTM
After-hours 18:46 (ET)3.810USD-0.065-1.68%
After-hours 18:46 (ET)Today
+2.37%
5 Days
-1.52%
1 Month
-16.20%
6 Months
-44.57%
Year to Date
-56.01%
1 Year
-10.80%
Key Figures
3.800Open
3.950High
199.51KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.33%Turnover Ratio
3.790Prev. Close
3.700Low
761.28KTurnover
LossP/E Static
1.17P/B
0.00%Div Yield TTM
-44.97%ROA
9.94052wk High
0.12Volume Ratio
-18.90MNet Profit
60.47MShares
-4.0541EPS TTM
0.63Beta
-60.48%ROE
3.70052wk Low
10.82%Amplitude
90.22%Gross Margin
234.62MMarket Cap
-0.52Reward/Risk
5.01%Risk Rate
Vanda Pharmaceuticals Inc's Score
0.12vs previous score
Forecast8.00
Financial Health6.43
Technical4.42
Valuation Dimensions8.20
Institutional Confidence7.00
Risk Assessment5.42
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Vanda Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Vanda Pharmaceuticals Inc Latest Earnings Call Transcripts
Vanda Pharmaceuticals (VNDA) Q3 2026 Earnings Call: Revenue Up 24%, Expenses Decline
Vanda Pharmaceuticals’ Q3 2026 earnings call covered 24% revenue growth, Fanapt momentum, lower sequential expenses and revenue guidance above $240 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.37/-0.68
Revenue / Forecast
69.81M/69.20M
Vanda Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolVNDA
Number of employees368
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 8.93% |
| Renaissance Technologies LLC | 5.62% |
| State Street Investment Management (US) | 5.01% |
| Vanguard Capital Management, LLC | 4.13% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 28.54% |
| Investment Advisor/Hedge Fund | 24.28% |
| Hedge Fund | 13.25% |
| Individual Investor | 6.16% |
Related Instruments
-0.46%
-0.97%
-2.05%
-0.78%
+0.45%
-0.04%
-0.12%
-0.21%
+1.13%
+0.49%
-1.03%
+0.86%
+0.38%
+2.73%
+3.60%
-0.77%
-0.40%
-0.19%
+1.54%
-2.00%
FAQs
What is the current price of Vanda Pharmaceuticals Inc (VNDA)?
The current price of Vanda Pharmaceuticals Inc (VNDA) is 3.88.
What is the symbol of Vanda Pharmaceuticals Inc?
The ticker symbol of Vanda Pharmaceuticals Inc is VNDA.
What is the 52-week high of Vanda Pharmaceuticals Inc?
The 52-week high of Vanda Pharmaceuticals Inc is 9.94.
What is the 52-week low of Vanda Pharmaceuticals Inc?
The 52-week low of Vanda Pharmaceuticals Inc is 3.70.
What is the market capitalization of Vanda Pharmaceuticals Inc?
The market capitalization of Vanda Pharmaceuticals Inc is 234.62M.
Is Vanda Pharmaceuticals Inc (VNDA) currently rated as Buy, Hold, or Sell?
According to analysts, Vanda Pharmaceuticals Inc (VNDA) has an overall rating of Buy, with a price target of 11.50.
What is the Earnings Per Share (EPS TTM) of Vanda Pharmaceuticals Inc (VNDA)?
The Earnings Per Share (EPS TTM) of Vanda Pharmaceuticals Inc (VNDA) is -4.05.